“Trend-jacking” or “news-jacking” is a term you’ll hear a lot at PR agencies, including PAN. We’re always looking for creative ways to get our clients meaningfully involved in industry conversations. While CEO profiles and cover stories are obvious homeruns in the media word, industry commentary can be just as valuable. And not getting included in a story on relevant news around a breaking trend can be a big miss, especially if your client's competitor is quoted.
For the businesses we represent at PAN in the healthcare and life sciences industries, a new FDA guidance can be a major opportunity to weigh in. A company executive can explain what this means – what should pharmaceutical companies be aware of? What are the implications here? With just a few sentences in a news article with this type of commentary, that spokesperson has established his or her expertise – important visibility to their company’s prospects and customers in the pharma community reading the article.
